Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Igelösa Life Science AB

Closing information (x1000 EUR)

Closing information 2023/12 2022/12 2021/12
Turnover 633 More Arrow 994 Less Arrow 929
Financial expenses 0 Equal arrow 0 Equal arrow 0
Earnings before taxes 78 More Arrow 136 Less Arrow 124
EBITDA 40 More Arrow 123 Less Arrow -194
Total assets 3,171 Less Arrow 3,080 More Arrow 3,388
Current assets 1,334 Less Arrow 1,232 More Arrow 1,358
Current liabilities 185 Less Arrow 160 More Arrow 323
Equity capital 2,972 Less Arrow 2,905 More Arrow 3,050
- share capital 90 Equal arrow 90 More Arrow 98
Employees (average) 9 More Arrow 10 Equal arrow 10

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 93.7% More Arrow 94.3% Less Arrow 90.0%
Turnover per employee 70 More Arrow 99 Less Arrow 93
Profit as a percentage of turnover 12.3% More Arrow 13.7% Less Arrow 13.3%
Return on assets (ROA) 2.5% More Arrow 4.4% Less Arrow 3.7%
Current ratio 721.1% More Arrow 770.0% Less Arrow 420.4%
Return on equity (ROE) 2.6% More Arrow 4.7% Less Arrow 4.1%
Change turnover -364 More Arrow 141 Less Arrow -92
Change turnover % -37% More Arrow 16% Less Arrow -9%
Chg. No. of employees -1 More Arrow 0 Less Arrow -3
Chg. No. of employees % -10% More Arrow 0% Less Arrow -23%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.